Who are the key players in the type 1 diabetes market?

Q: Who are the key players in the type 1 diabetes market?

Some of the key players are Abbott, Bayer, Eli Lilly, BD, Johnson & Johnson, Merck, Pfizer Inc, Astrazeneca plc, Roche, Smiths Medical, Medtronic Inc, China, Bayer AG, India, Others.

Global Type 1 Diabetes Market Insights, Forecast to 2028

Code: QYRE-Auto-32X2217

Report

April 2022

108 Pages

QYResearch

Region: Global, North America, Japan, Europe, Central & South America,

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Abbott

Bayer

Eli Lilly

Johnson & Johnson

Merck

Pfizer Inc

Astrazeneca plc

Roche

Smiths Medical

Medtronic Inc

China

Bayer AG

India

Market Analysis and Insights: Global Type 1 Diabetes Market

The global Type 1 Diabetes market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Rapid Acting Insulin Analogs accounting for % of the Type 1 Diabetes global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Type 1 Diabetes market size is valued at US$ million in 2021, while the North America and Europe Type 1 Diabetes are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Type 1 Diabetes landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Type 1 Diabetes market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Type 1 Diabetes market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Type 1 Diabetes market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Type 1 Diabetes market.

Global Type 1 Diabetes Scope and Market Size

Type 1 Diabetes market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Type 1 Diabetes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Rapid Acting Insulin Analogs

Long Acting Insulin Analogs

Premix Insulin Analogs

Segment by Application

Hospitals

Diagnostic clinics

BY COMPANY

Abbott

Bayer

Eli Lilly

Johnson & Johnson

Merck

Pfizer

AstraZeneca

Roche

Smiths Medical

Medtronic

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

Abbott

Bayer

Eli Lilly

Johnson & Johnson

Merck

Pfizer Inc

Astrazeneca plc

Roche

Smiths Medical

Medtronic Inc

China

Bayer AG

India

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Type 1 Diabetes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Rapid Acting Insulin Analogs

1.2.3 Long Acting Insulin Analogs

1.2.4 Premix Insulin Analogs

1.3 Market by Application

1.3.1 Global Type 1 Diabetes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Diagnostic clinics

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Type 1 Diabetes Market Perspective (2017-2028)

2.2 Type 1 Diabetes Growth Trends by Region

2.2.1 Type 1 Diabetes Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Type 1 Diabetes Historic Market Size by Region (2017-2022)

2.2.3 Type 1 Diabetes Forecasted Market Size by Region (2023-2028)

2.3 Type 1 Diabetes Market Dynamics

2.3.1 Type 1 Diabetes Industry Trends

2.3.2 Type 1 Diabetes Market Drivers

2.3.3 Type 1 Diabetes Market Challenges

2.3.4 Type 1 Diabetes Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Type 1 Diabetes Players by Revenue

3.1.1 Global Top Type 1 Diabetes Players by Revenue (2017-2022)

3.1.2 Global Type 1 Diabetes Revenue Market Share by Players (2017-2022)

3.2 Global Type 1 Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Type 1 Diabetes Revenue

3.4 Global Type 1 Diabetes Market Concentration Ratio

3.4.1 Global Type 1 Diabetes Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Type 1 Diabetes Revenue in 2021

3.5 Type 1 Diabetes Key Players Head office and Area Served

3.6 Key Players Type 1 Diabetes Product Solution and Service

3.7 Date of Enter into Type 1 Diabetes Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Type 1 Diabetes Breakdown Data by Type

4.1 Global Type 1 Diabetes Historic Market Size by Type (2017-2022)

4.2 Global Type 1 Diabetes Forecasted Market Size by Type (2023-2028)

5 Type 1 Diabetes Breakdown Data by Application

5.1 Global Type 1 Diabetes Historic Market Size by Application (2017-2022)

5.2 Global Type 1 Diabetes Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Type 1 Diabetes Market Size (2017-2028)

6.2 North America Type 1 Diabetes Market Size by Type

6.2.1 North America Type 1 Diabetes Market Size by Type (2017-2022)

6.2.2 North America Type 1 Diabetes Market Size by Type (2023-2028)

6.2.3 North America Type 1 Diabetes Market Share by Type (2017-2028)

6.3 North America Type 1 Diabetes Market Size by Application

6.3.1 North America Type 1 Diabetes Market Size by Application (2017-2022)

6.3.2 North America Type 1 Diabetes Market Size by Application (2023-2028)

6.3.3 North America Type 1 Diabetes Market Share by Application (2017-2028)

6.4 North America Type 1 Diabetes Market Size by Country

6.4.1 North America Type 1 Diabetes Market Size by Country (2017-2022)

6.4.2 North America Type 1 Diabetes Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Type 1 Diabetes Market Size (2017-2028)

7.2 Europe Type 1 Diabetes Market Size by Type

7.2.1 Europe Type 1 Diabetes Market Size by Type (2017-2022)

7.2.2 Europe Type 1 Diabetes Market Size by Type (2023-2028)

7.2.3 Europe Type 1 Diabetes Market Share by Type (2017-2028)

7.3 Europe Type 1 Diabetes Market Size by Application

7.3.1 Europe Type 1 Diabetes Market Size by Application (2017-2022)

7.3.2 Europe Type 1 Diabetes Market Size by Application (2023-2028)

7.3.3 Europe Type 1 Diabetes Market Share by Application (2017-2028)

7.4 Europe Type 1 Diabetes Market Size by Country

7.4.1 Europe Type 1 Diabetes Market Size by Country (2017-2022)

7.4.2 Europe Type 1 Diabetes Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Type 1 Diabetes Market Size (2017-2028)

8.2 Asia-Pacific Type 1 Diabetes Market Size by Type

8.2.1 Asia-Pacific Type 1 Diabetes Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Type 1 Diabetes Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Type 1 Diabetes Market Share by Type (2017-2028)

8.3 Asia-Pacific Type 1 Diabetes Market Size by Application

8.3.1 Asia-Pacific Type 1 Diabetes Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Type 1 Diabetes Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Type 1 Diabetes Market Share by Application (2017-2028)

8.4 Asia-Pacific Type 1 Diabetes Market Size by Region

8.4.1 Asia-Pacific Type 1 Diabetes Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Type 1 Diabetes Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Type 1 Diabetes Market Size (2017-2028)

9.2 Latin America Type 1 Diabetes Market Size by Type

9.2.1 Latin America Type 1 Diabetes Market Size by Type (2017-2022)

9.2.2 Latin America Type 1 Diabetes Market Size by Type (2023-2028)

9.2.3 Latin America Type 1 Diabetes Market Share by Type (2017-2028)

9.3 Latin America Type 1 Diabetes Market Size by Application

9.3.1 Latin America Type 1 Diabetes Market Size by Application (2017-2022)

9.3.2 Latin America Type 1 Diabetes Market Size by Application (2023-2028)

9.3.3 Latin America Type 1 Diabetes Market Share by Application (2017-2028)

9.4 Latin America Type 1 Diabetes Market Size by Country

9.4.1 Latin America Type 1 Diabetes Market Size by Country (2017-2022)

9.4.2 Latin America Type 1 Diabetes Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Type 1 Diabetes Market Size (2017-2028)

10.2 Middle East & Africa Type 1 Diabetes Market Size by Type

10.2.1 Middle East & Africa Type 1 Diabetes Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Type 1 Diabetes Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Type 1 Diabetes Market Share by Type (2017-2028)

10.3 Middle East & Africa Type 1 Diabetes Market Size by Application

10.3.1 Middle East & Africa Type 1 Diabetes Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Type 1 Diabetes Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Type 1 Diabetes Market Share by Application (2017-2028)

10.4 Middle East & Africa Type 1 Diabetes Market Size by Country

10.4.1 Middle East & Africa Type 1 Diabetes Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Type 1 Diabetes Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Type 1 Diabetes Introduction

11.1.4 Abbott Revenue in Type 1 Diabetes Business (2017-2022)

11.1.5 Abbott Recent Developments

11.2 Bayer

11.2.1 Bayer Company Details

11.2.2 Bayer Business Overview

11.2.3 Bayer Type 1 Diabetes Introduction

11.2.4 Bayer Revenue in Type 1 Diabetes Business (2017-2022)

11.2.5 Bayer Recent Developments

11.3 Eli Lilly

11.3.1 Eli Lilly Company Details

11.3.2 Eli Lilly Business Overview

11.3.3 Eli Lilly Type 1 Diabetes Introduction

11.3.4 Eli Lilly Revenue in Type 1 Diabetes Business (2017-2022)

11.3.5 Eli Lilly Recent Developments

11.4 BD

11.4.1 BD Company Details

11.4.2 BD Business Overview

11.4.3 BD Type 1 Diabetes Introduction

11.4.4 BD Revenue in Type 1 Diabetes Business (2017-2022)

11.4.5 BD Recent Developments

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Type 1 Diabetes Introduction

11.5.4 Johnson & Johnson Revenue in Type 1 Diabetes Business (2017-2022)

11.5.5 Johnson & Johnson Recent Developments

11.6 Merck

11.6.1 Merck Company Details

11.6.2 Merck Business Overview

11.6.3 Merck Type 1 Diabetes Introduction

11.6.4 Merck Revenue in Type 1 Diabetes Business (2017-2022)

11.6.5 Merck Recent Developments

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Type 1 Diabetes Introduction

11.7.4 Pfizer Revenue in Type 1 Diabetes Business (2017-2022)

11.7.5 Pfizer Recent Developments

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Type 1 Diabetes Introduction

11.8.4 AstraZeneca Revenue in Type 1 Diabetes Business (2017-2022)

11.8.5 AstraZeneca Recent Developments

11.9 Roche

11.9.1 Roche Company Details

11.9.2 Roche Business Overview

11.9.3 Roche Type 1 Diabetes Introduction

11.9.4 Roche Revenue in Type 1 Diabetes Business (2017-2022)

11.9.5 Roche Recent Developments

11.10 Smiths Medical

11.10.1 Smiths Medical Company Details

11.10.2 Smiths Medical Business Overview

11.10.3 Smiths Medical Type 1 Diabetes Introduction

11.10.4 Smiths Medical Revenue in Type 1 Diabetes Business (2017-2022)

11.10.5 Smiths Medical Recent Developments

11.11 Medtronic

11.11.1 Medtronic Company Details

11.11.2 Medtronic Business Overview

11.11.3 Medtronic Type 1 Diabetes Introduction

11.11.4 Medtronic Revenue in Type 1 Diabetes Business (2017-2022)

11.11.5 Medtronic Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott

Bayer

Eli Lilly

Johnson & Johnson

Merck

Pfizer Inc

Astrazeneca plc

Roche

Smiths Medical

Medtronic Inc

China

Bayer AG

India

List of Tables

Table 1. Global Type 1 Diabetes Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Rapid Acting Insulin Analogs

Table 3. Key Players of Long Acting Insulin Analogs

Table 4. Key Players of Premix Insulin Analogs

Table 5. Global Type 1 Diabetes Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 6. Global Type 1 Diabetes Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 7. Global Type 1 Diabetes Market Size by Region (2017-2022) & (US$ Million)

Table 8. Global Type 1 Diabetes Market Share by Region (2017-2022)

Table 9. Global Type 1 Diabetes Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 10. Global Type 1 Diabetes Market Share by Region (2023-2028)

Table 11. Type 1 Diabetes Market Trends

Table 12. Type 1 Diabetes Market Drivers

Table 13. Type 1 Diabetes Market Challenges

Table 14. Type 1 Diabetes Market Restraints

Table 15. Global Type 1 Diabetes Revenue by Players (2017-2022) & (US$ Million)

Table 16. Global Type 1 Diabetes Revenue Share by Players (2017-2022)

Table 17. Global Top Type 1 Diabetes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 1 Diabetes as of 2021)

Table 18. Ranking of Global Top Type 1 Diabetes Companies by Revenue (US$ Million) in 2021

Table 19. Global 5 Largest Players Market Share by Type 1 Diabetes Revenue (CR5 and HHI) & (2017-2022)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Type 1 Diabetes Product Solution and Service

Table 22. Date of Enter into Type 1 Diabetes Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)

Table 25. Global Type 1 Diabetes Revenue Market Share by Type (2017-2022)

Table 26. Global Type 1 Diabetes Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 27. Global Type 1 Diabetes Revenue Market Share by Type (2023-2028)

Table 28. Global Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)

Table 29. Global Type 1 Diabetes Revenue Share by Application (2017-2022)

Table 30. Global Type 1 Diabetes Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 31. Global Type 1 Diabetes Revenue Share by Application (2023-2028)

Table 32. North America Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)

Table 33. North America Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)

Table 34. North America Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)

Table 35. North America Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)

Table 36. North America Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)

Table 37. North America Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)

Table 38. Europe Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)

Table 39. Europe Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)

Table 40. Europe Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)

Table 41. Europe Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)

Table 42. Europe Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)

Table 43. Europe Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)

Table 44. Asia Pacific Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)

Table 45. Asia Pacific Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)

Table 46. Asia Pacific Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)

Table 47. Asia Pacific Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)

Table 48. Asia Pacific Type 1 Diabetes Market Size by Region (2017-2022) & (US$ Million)

Table 49. Asia Pacific Type 1 Diabetes Market Size by Region (2023-2028) & (US$ Million)

Table 50. Latin America Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)

Table 51. Latin America Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)

Table 52. Latin America Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)

Table 53. Latin America Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)

Table 54. Latin America Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)

Table 55. Latin America Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)

Table 56. Middle East and Africa Type 1 Diabetes Market Size by Type (2017-2022) & (US$ Million)

Table 57. Middle East and Africa Type 1 Diabetes Market Size by Type (2023-2028) & (US$ Million)

Table 58. Middle East and Africa Type 1 Diabetes Market Size by Application (2017-2022) & (US$ Million)

Table 59. Middle East and Africa Type 1 Diabetes Market Size by Application (2023-2028) & (US$ Million)

Table 60. Middle East and Africa Type 1 Diabetes Market Size by Country (2017-2022) & (US$ Million)

Table 61. Middle East and Africa Type 1 Diabetes Market Size by Country (2023-2028) & (US$ Million)

Table 62. Abbott Company Details

Table 63. Abbott Business Overview

Table 64. Abbott Type 1 Diabetes Product

Table 65. Abbott Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)

Table 66. Abbott Recent Developments

Table 67. Bayer Company Details

Table 68. Bayer Business Overview

Table 69. Bayer Type 1 Diabetes Product

Table 70. Bayer Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)

Table 71. Bayer Recent Developments

Table 72. Eli Lilly Company Details

Table 73. Eli Lilly Business Overview

Table 74. Eli Lilly Type 1 Diabetes Product

Table 75. Eli Lilly Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)

Table 76. Eli Lilly Recent Developments

Table 77. BD Company Details

Table 78. BD Business Overview

Table 79. BD Type 1 Diabetes Product

Table 80. BD Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)

Table 81. BD Recent Developments

Table 82. Johnson & Johnson Company Details

Table 83. Johnson & Johnson Business Overview

Table 84. Johnson & Johnson Type 1 Diabetes Product

Table 85. Johnson & Johnson Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)

Table 86. Johnson & Johnson Recent Developments

Table 87. Merck Company Details

Table 88. Merck Business Overview

Table 89. Merck Type 1 Diabetes Product

Table 90. Merck Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)

Table 91. Merck Recent Developments

Table 92. Pfizer Company Details

Table 93. Pfizer Business Overview

Table 94. Pfizer Type 1 Diabetes Product

Table 95. Pfizer Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)

Table 96. Pfizer Recent Developments

Table 97. AstraZeneca Company Details

Table 98. AstraZeneca Business Overview

Table 99. AstraZeneca Type 1 Diabetes Product

Table 100. AstraZeneca Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)

Table 101. AstraZeneca Recent Developments

Table 102. Roche Company Details

Table 103. Roche Business Overview

Table 104. Roche Type 1 Diabetes Product

Table 105. Roche Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)

Table 106. Roche Recent Developments

Table 107. Smiths Medical Company Details

Table 108. Smiths Medical Business Overview

Table 109. Smiths Medical Type 1 Diabetes Product

Table 110. Smiths Medical Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)

Table 111. Smiths Medical Recent Developments

Table 112. Medtronic Company Details

Table 113. Medtronic Business Overview

Table 114. Medtronic Type 1 Diabetes Product

Table 115. Medtronic Revenue in Type 1 Diabetes Business (2017-2022) & (US$ Million)

Table 116. Medtronic Recent Developments

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Type 1 Diabetes Market Share by Type: 2021 VS 2028

Figure 2. Rapid Acting Insulin Analogs Features

Figure 3. Long Acting Insulin Analogs Features

Figure 4. Premix Insulin Analogs Features

Figure 5. Global Type 1 Diabetes Market Share by Application: 2021 VS 2028

Figure 6. Hospitals Case Studies

Figure 7. Diagnostic clinics Case Studies

Figure 8. Type 1 Diabetes Report Years Considered

Figure 9. Global Type 1 Diabetes Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 10. Global Type 1 Diabetes Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global Type 1 Diabetes Market Share by Region: 2021 VS 2028

Figure 12. Global Type 1 Diabetes Market Share by Players in 2021

Figure 13. Global Top Type 1 Diabetes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 1 Diabetes as of 2021)

Figure 14. The Top 10 and 5 Players Market Share by Type 1 Diabetes Revenue in 2021

Figure 15. North America Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)

Figure 16. North America Type 1 Diabetes Market Size Market Share by Type (2017-2028)

Figure 17. North America Type 1 Diabetes Market Size Market Share by Application (2017-2028)

Figure 18. North America Type 1 Diabetes Market Size Share by Country (2017-2028)

Figure 19. United States Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 20. Canada Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 21. Europe Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)

Figure 22. Europe Type 1 Diabetes Market Size Market Share by Type (2017-2028)

Figure 23. Europe Type 1 Diabetes Market Size Market Share by Application (2017-2028)

Figure 24. Europe Type 1 Diabetes Market Size Share by Country (2017-2028)

Figure 25. Germany Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 26. France Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. U.K. Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. Italy Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. Russia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Nordic Countries Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Asia-Pacific Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)

Figure 32. Asia Pacific Type 1 Diabetes Market Size Market Share by Type (2017-2028)

Figure 33. Asia Pacific Type 1 Diabetes Market Size Market Share by Application (2017-2028)

Figure 34. Asia Pacific Type 1 Diabetes Market Size Share by Region (2017-2028)

Figure 35. China Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 36. Japan Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 37. South Korea Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Southeast Asia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. India Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Australia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 41. Latin America Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)

Figure 42. Latin America Type 1 Diabetes Market Size Market Share by Type (2017-2028)

Figure 43. Latin America Type 1 Diabetes Market Size Market Share by Application (2017-2028)

Figure 44. Latin America Type 1 Diabetes Market Size Share by Country (2017-2028)

Figure 45. Mexico Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 46. Brazil Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 47. Middle East & Africa Type 1 Diabetes Market Size YoY (2017-2028) & (US$ Million)

Figure 48. Middle East and Africa Type 1 Diabetes Market Size Market Share by Type (2017-2028)

Figure 49. Middle East and Africa Type 1 Diabetes Market Size Market Share by Application (2017-2028)

Figure 50. Middle East and Africa Type 1 Diabetes Market Size Share by Country (2017-2028)

Figure 51. Turkey Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 52. Saudi Arabia Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 53. UAE Type 1 Diabetes Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. Abbott Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)

Figure 55. Bayer Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)

Figure 56. Eli Lilly Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)

Figure 57. BD Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)

Figure 58. Johnson & Johnson Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)

Figure 59. Merck Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)

Figure 60. Pfizer Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)

Figure 61. AstraZeneca Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)

Figure 62. Roche Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)

Figure 63. Smiths Medical Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)

Figure 64. Medtronic Revenue Growth Rate in Type 1 Diabetes Business (2017-2022)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

REPORTS VIEWED RECENTLY

Global Type 1 Diabetes Market Insights, Forecast to 2028

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Type 1 Diabetes Market Insights, Forecast to 2028

Published Date: April 2022

Report Code: QYRE-Auto-32X2217

Global Type 1 Diabetes Market Insights, Forecast to 2028

Code: QYRE-Auto-32X2217

Report

April 2022

108 Pages

QYResearch

Region: Global, North America, Japan, Europe, Central & South America,

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

REPORTS VIEWED RECENTLY

SELECT A FORMAT

Single User

Electronic (PDF)

$4900

Multi User

Electronic (PDF)

$7350

Enterprise User

Electronic (PDF)

$9800

HAVE A QUERY?

OUR CUSTOMER

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-37X10341

Tue Jun 07 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-9F2714

Fri Apr 08 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-5X8306

Fri Apr 08 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-33T8000

Fri Apr 08 00:00:00 UTC 2022

Add to Cart

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions